We invite you to join us for a Challenging Case Activity, where expert faculty will explore strategies for personalizing APDS management, with a focus on key treatment considerations and the latest clinical evidence.

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a significant health burden, affecting about 25% to 30% of the 28.9 million US adults with chronic rhinosinusitis.